On July 11, 2012, Merus Labs International Inc. acquired Emselex®/Enablex®. Stewart Muglich and Victor Dudas of our Corporate Finance & Securities Group handled the debt facility between Merus and PDL BioPharma Inc., a company that supports the healthcare industry with creative financing solutions, assisted by Amaan Gangji and Kevin MacDonald. The transaction involved counsel from Toronto, New York, Switzerland, the Netherlands and Luxembourg.
Related Content
CIPO Seeks Consultation On More Proposed Changes
CIPO seeks consultation on proposed changes: not having to confirm applicant is a “person”, adding colour, automatic deemed withdrawal of opositions
Insurance Covenants: Paying For Insurance is No Guarantee of Tort Immunity
Edited by Samantha Ip The Ontario Court of Appeal has made a clear statement on an insurer’s right to make a subrogated claim in the ... Continued
Leaving a legacy: Loran and Carol
For Loran and Carol Wright, charitable giving isn’t a conscious decision—it’s an ingrained act that is as natural as breathing. They have early memories of ... Continued